Details of the Drug-Related molecule(s) Interaction Atlas

General Information of DTT (ID: TTER58P)

• DTT Name: B- and T-lymphocyte attenuator (BTLA) DTT Info
• Gene Name: BTLA

Molecule-Related Drug & Molecule List

2 Clinical Trial Drug(s) Transported by This DTP

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
LY3361237	DMHXMYU	Sjogren syndrome	4A43.20	Phase 2	[1]
JS004	DMFMWLQ	Solid tumour/cancer	2A00-2F9Z	Phase 1	[2]

References

• [1] ClinicalTrials.gov (NCT05781451) A Phase 2, Open Label Study of Anti-BTLA Agonist Therapy in Subjects With Primary Sjogren's Syndrome. U.S.National Institutes of Health.
• [2] Clinical pipeline report, company report or official report of Junshi Biosciences.